Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q1100864> ?p ?o }
Showing triples 1 to 38 of
38
with 100 triples per page.
- Q1100864 subject Q15805258.
- Q1100864 subject Q7335351.
- Q1100864 subject Q9052323.
- Q1100864 subject Q9738278.
- Q1100864 abstract "Clevudine (INN) is an antiviral drug for the treatment of hepatitis B (HBV). It is already approved for HBV in South Korea and the Philippines. It is marketed by Bukwang Pharmaceuticals in South Korea under the tradenames Levovir and Revovir.Under license from Bukwang, Pharmasset was developing the drug, but its phase III clinical trial (international, multicenter, randomized, double-blind, 96 week QUASH studies) was terminated due to some myopathy cases in patients. Its approval in South Korea was revoked following these findings. Researchers in South Korea are testing clevudine at lower doses in combination with adefovir for continued use. It is a nucleoside analog.".
- Q1100864 atcPrefix "J05".
- Q1100864 atcSuffix "AF12".
- Q1100864 casNumber "69256-17-3".
- Q1100864 fdaUniiCode "IN51MVP5F1".
- Q1100864 iupacName "1-[(2S,3R,4S,5S)-3-fluoro-4-hydroxy-5- (hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine- 2,4-dione".
- Q1100864 pubchem "73115".
- Q1100864 thumbnail Clevudine_Formulae.png?width=300.
- Q1100864 wikiPageWikiLink Q15805258.
- Q1100864 wikiPageWikiLink Q2689559.
- Q1100864 wikiPageWikiLink Q353551.
- Q1100864 wikiPageWikiLink Q6853.
- Q1100864 wikiPageWikiLink Q692536.
- Q1100864 wikiPageWikiLink Q7180839.
- Q1100864 wikiPageWikiLink Q7335351.
- Q1100864 wikiPageWikiLink Q824258.
- Q1100864 wikiPageWikiLink Q884.
- Q1100864 wikiPageWikiLink Q9052323.
- Q1100864 wikiPageWikiLink Q928.
- Q1100864 wikiPageWikiLink Q9738278.
- Q1100864 atcPrefix "J05".
- Q1100864 atcSuffix "AF12".
- Q1100864 casNumber "69256".
- Q1100864 iupacName "1".
- Q1100864 pubchem "73115".
- Q1100864 unii "IN51MVP5F1".
- Q1100864 type ChemicalSubstance.
- Q1100864 type Drug.
- Q1100864 type ChemicalObject.
- Q1100864 type Thing.
- Q1100864 type Q8386.
- Q1100864 comment "Clevudine (INN) is an antiviral drug for the treatment of hepatitis B (HBV). It is already approved for HBV in South Korea and the Philippines. It is marketed by Bukwang Pharmaceuticals in South Korea under the tradenames Levovir and Revovir.Under license from Bukwang, Pharmasset was developing the drug, but its phase III clinical trial (international, multicenter, randomized, double-blind, 96 week QUASH studies) was terminated due to some myopathy cases in patients.".
- Q1100864 label "Clevudine".
- Q1100864 depiction Clevudine_Formulae.png.